115 related articles for article (PubMed ID: 22821889)
21. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels.
Martina M; Gorfinkel Y; Halman S; Lowe JA; Periyalwar P; Schmidt CJ; Bergeron R
J Physiol; 2004 Jun; 557(Pt 2):489-500. PubMed ID: 15064326
[TBL] [Abstract][Full Text] [Related]
22. L-2-chloropropionic acid inhibits glutamate and aspartate release from rat cerebellar slices but does not activate cerebellar NMDA receptors: implications for L-2-chloropropionic acid-induced neurotoxicity.
Widdowson PS; Briggs I; BoSmith RE; Sturgess NC; Rosbottom A; Smith JC; Wyatt I
Neurotoxicology; 1997; 18(1):169-77. PubMed ID: 9215999
[TBL] [Abstract][Full Text] [Related]
23. Highly differential expression of SN1, a bidirectional glutamine transporter, in astroglia and endothelium in the developing rat brain.
Boulland JL; Rafiki A; Levy LM; Storm-Mathisen J; Chaudhry FA
Glia; 2003 Feb; 41(3):260-75. PubMed ID: 12528181
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C-mediated phosphorylation of a single serine residue on the rat glial glutamine transporter SN1 governs its membrane trafficking.
Nissen-Meyer LS; Popescu MC; Hamdani el H; Chaudhry FA
J Neurosci; 2011 Apr; 31(17):6565-75. PubMed ID: 21525297
[TBL] [Abstract][Full Text] [Related]
25. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
26. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission.
Leonetti M; Desvignes C; Bougault I; Souilhac J; Oury-Donat F; Steinberg R
Neuroscience; 2006; 137(2):555-64. PubMed ID: 16289893
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of substrate transport-induced clustering of a glial glutamate transporter GLT-1 in astroglial-neuronal cultures.
Nakagawa T; Otsubo Y; Yatani Y; Shirakawa H; Kaneko S
Eur J Neurosci; 2008 Nov; 28(9):1719-30. PubMed ID: 18973588
[TBL] [Abstract][Full Text] [Related]
29. High-affinity glycine and glutamate transport in pig forebrain white and gray matter: a quantitative study.
Henjum S; Hassel B
Neurochem Int; 2007 Apr; 50(5):696-702. PubMed ID: 17316904
[TBL] [Abstract][Full Text] [Related]
30. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits.
Chatterton JE; Awobuluyi M; Premkumar LS; Takahashi H; Talantova M; Shin Y; Cui J; Tu S; Sevarino KA; Nakanishi N; Tong G; Lipton SA; Zhang D
Nature; 2002 Feb; 415(6873):793-8. PubMed ID: 11823786
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid.
Grintal B; Champeil-Potokar G; Lavialle M; Vancassel S; Breton S; Denis I
Neurochem Int; 2009 Jul; 54(8):535-43. PubMed ID: 19428799
[TBL] [Abstract][Full Text] [Related]
32. SNAT3-mediated glutamine transport in perisynaptic astrocytes in situ is regulated by intracellular sodium.
Todd AC; Marx MC; Hulme SR; Bröer S; Billups B
Glia; 2017 Jun; 65(6):900-916. PubMed ID: 28272791
[TBL] [Abstract][Full Text] [Related]
33. Glutamine efflux from astrocytes is mediated by multiple pathways.
Deitmer JW; Bröer A; Bröer S
J Neurochem; 2003 Oct; 87(1):127-35. PubMed ID: 12969260
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
[TBL] [Abstract][Full Text] [Related]
35. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
36. Cloning and functional characterization of a new subtype of the amino acid transport system N.
Nakanishi T; Kekuda R; Fei YJ; Hatanaka T; Sugawara M; Martindale RG; Leibach FH; Prasad PD; Ganapathy V
Am J Physiol Cell Physiol; 2001 Dec; 281(6):C1757-68. PubMed ID: 11698233
[TBL] [Abstract][Full Text] [Related]
37. Bidirectional substrate fluxes through the system N (SNAT5) glutamine transporter may determine net glutamine flux in rat liver.
Baird FE; Beattie KJ; Hyde AR; Ganapathy V; Rennie MJ; Taylor PM
J Physiol; 2004 Sep; 559(Pt 2):367-81. PubMed ID: 15218073
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
[TBL] [Abstract][Full Text] [Related]
39. Ncm-D-aspartate: a novel caged D-aspartate suitable for activation of glutamate transporters and N-methyl-D-aspartate (NMDA) receptors in brain tissue.
Huang YH; Muralidharan S; Sinha SR; Kao JP; Bergles DE
Neuropharmacology; 2005 Nov; 49(6):831-42. PubMed ID: 16169022
[TBL] [Abstract][Full Text] [Related]
40. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
Yang CR; Svensson KA
Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
